Ghost Tree Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History

Ghost Tree Capital’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-500,000	Closed	-$2.08M	–	68
2017 Q4	$2.08M	Sell	500,000 -450,000	-47%	-$2.71M	0.49%	45
2017 Q3	$9.15M	Buy	950,000 +125,000	+15%	+$1.3M	1.94%	19
2017 Q2	$9.76M	Buy	825,000 +175,000	+27%	+$2.24M	2.03%	16
2017 Q1	$8.33M	Buy	+650,000	New	+$7.82M	1.55%	27
2016 Q2	–	Sell	-300,000	Closed	-$1.58M	–	84
2016 Q1	$1.58M	Sell	300,000 -110,000	-27%	-$612K	0.89%	37
2015 Q4	$3.18M	Sell	410,000 -115,000	-22%	-$883K	1.3%	30
2015 Q3	$4.13M	Sell	525,000 -225,000	-30%	-$2.08M	1.86%	20
2015 Q2	$6.79M	Buy	+750,000	New	+$7.56M	2.2%	14
2014 Q1	–	Sell	-190,000	Closed	-$2.52M	–	83
2013 Q4	$2.52M	Buy	+190,000	New	+$2.31M	1.55%	27

Other funds holding GNMK

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Ghost Tree Capital's GNMK Position: Q1 2018 in Review

Ghost Tree Capital sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2018, closing a stake of 500,000 shares — an estimated $2.08M sold.

Ghost Tree Capital first reported a position in GNMK in Q4 2013 and held it in 9 quarters. The position peaked at $9.76M in Q2 2017. 98 funds tracked by Wall St. Rank hold GNMK as of Q1 2018.

Ghost Tree Capital reported no remaining GenMark Diagnostics, Inc position as of Q1 2018 after selling out during the quarter.
Ghost Tree Capital sold 500,000 GenMark Diagnostics, Inc shares in Q1 2018, an estimated $2.08M.
Ghost Tree Capital first reported a position in GenMark Diagnostics, Inc in Q4 2013 and held it in 9 quarters.
Ghost Tree Capital's GenMark Diagnostics, Inc position peaked at $9.76M in Q2 2017.
98 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2018.

Based on Ghost Tree Capital's 13F filing for Q1 2018, filed 15 May 2018.